Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Limited data are available regarding psychosocial distress at the time of diagnosis of ulcerative colitis (UC). We investigated the psychosocial burden and factors related to poor health-related quality of life (HRQL) among patients newly diagnosed with moderate-to-severe UC who were affiliated with the nationwide prospective cohort study. Methods: Within the first 4 weeks of UC diagnosis, all patients were assessed using the Hospital Anxiety and Depression Scale (HADS), Work Productivity and Activity Impairment questionnaire, Inflammatory Bowel Disease Questionnaire (IBDQ), and 12-Item Short Form (SF-12) health survey. A multiple linear regression model was used to identify factors associated with HRQL. Results: Between August 2014 and February 2017, 355 patients completed questionnaires. Significant mood disorders requiring psychological interventions, defined by a HADS score ≥11, were identified in 16.7% (anxiety) and 20.6% (depression) of patients. Patients with severe disease were more likely to have presenteeism, loss of work productivity, and activity loss than those with moderate disease (all p<0.05). Significant mood disorders had the strongest negative relationship with total IBDQ score, which indicates disease-specific HRQL (β coefficient: –22.1 for depression and –40.0 for anxiety, p<0.001). The scores of all SF-12 dimensions, which indicate general HRQL, were remarkably decreased in the study population compared indirectly with previously reported scores in the general population. The Mayo score, C-reactive protein level, and white blood cell count showed significant negative associations with the IBDQ score (p<0.05). Conclusions: Psychosocial screening and timely interventions should be incorporated into the initial care of patients newly diagnosed with UC.
Abstract
Background/Aims: Limited data are available regarding psychosocial distress at the time of diagnosis of ulcerative colitis (UC). We investigated the psychosocial burden and factors related to poor health-related quality of life (HRQL) among patients newly diagnosed with moderate-to-severe UC who were affiliated with the nationwide prospective cohort study. Methods: Within the first 4 weeks of UC diagnosis, all patients were assessed using the Hospital Anxiety and Depression Scale (HADS), Work Productivity and Activity Impairment questionnaire, Inflammatory Bowel Disease Questionnaire (IBDQ), and 12-Item Short Form (SF-12) health survey. A multiple linear regression model was used to identify factors associated with HRQL. Results: Between August 2014 and February 2017, 355 patients completed questionnaires. Significant mood disorders requiring psychological interventions, defined by a HADS score ≥11, were identified in 16.7% (anxiety) and 20.6% (depression) of patients. Patients with severe disease were more likely to have presenteeism, loss of work productivity, and activity loss than those with moderate disease (all p<0.05). Significant mood disorders had the strongest negative relationship with total IBDQ score, which indicates disease-specific HRQL (β coefficient: –22.1 for depression and –40.0 for anxiety, p<0.001). The scores of all SF-12 dimensions, which indicate general HRQL, were remarkably decreased in the study population compared indirectly with previously reported scores in the general population. The Mayo score, C-reactive protein level, and white blood cell count showed significant negative associations with the IBDQ score (p<0.05). Conclusions: Psychosocial screening and timely interventions should be incorporated into the initial care of patients newly diagnosed with UC.
참고문헌 (49)
- Irvine EJ, "Quality of life of patients with ulcerative colitis : past, present, and future", Inflamm Bowel Dis, 14, pp.554~565 (2008)
- Yarlas A, "Burden of ulcerative colitis on functioning and well-being : a systematic literature review of the SF-36® health survey", J Crohns Colitis, 12, pp.600~609 (2018)
- Williet N, "Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease", Clin Gastroenterol Hepatol, 12, pp.1246~1256 (2014)
- Feagan BG, "Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis : results from the randomised GEMINI 1 trial", Aliment Pharmacol Ther, 45, pp.264~275 (2017)
- Han SW, "Predictors of quality of life in ulcerative colitis : the importance of symptoms and illness representations", Inflamm Bowel Dis, 11, pp.24~34 (2005)
- Hoivik ML, "Health-related quality of life in patients with ulcerative colitis after a 10-year disease course : results from the IBSEN study", Inflamm Bowel Dis, 18, pp.1540~1549 (2012)
- Zheng K, "Health-related quality of life in Chinese patients with mild and moderately active ulcerative colitis", PLoS One, 10, pp.e0124211~ (2015)
- Gibson PR, "Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia : a crosssectional, observational study", J Crohns Colitis, 8, pp.598~606 (2014)
- Ghosh S, "Impact of inflammatory bowel disease on quality of life : results of the European Federation of Crohn's and Ulcerative Colitis Associations(EFCCA)patient survey", J Crohns Colitis, 1, pp.10~20 (2007)
- Walker JR, "The Manitoba IBD cohort study : a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders", Am J Gastroenterol, 103, pp.1989~1997 (2008)
- Iglesias-Rey M, "Psychological factors are associated with changes in the healthrelated quality of life in inflammatory bowel disease", Inflamm Bowel Dis, 20, pp.92~102 (2014)
- Bernstein CN, "Psychological stress and depression : risk factors for IBD", Dig Dis, 34, pp.58~63 (2016)
- Viganò CA, "Alexithymia and psychopathology in patients suffering from inflammatory bowel disease : arising differences and correlations to tailoring therapeutic strategies", Front Psychiatry, 9, pp.324~ (2018)
- Cohen BL, "Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity", Aliment Pharmacol Ther, 39, pp.811~822 (2014)
- 윤진영, "Disability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of Life", Gut and Liver, 11(3), pp.370~376 (2017), 거트앤리버 소화기연관학회협의회
- 김영선, "Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases", Intestinal research, 15(3), pp.338~344 (2017), 대한장연구학회
- Ng SC, "Epidemiology of inflammatory bowel disease : focus on Asia", Best Pract Res Clin Gastroenterol, 28, pp.363~372 (2014)
- Kim HJ, "Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012 : a nationwide population-based study", Inflamm Bowel Dis, 21, pp.623~630 (2015)
- Kim JW, "Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea : a nationwide population-based study", J Gastroenterol Hepatol, 33, pp.847~854 (2018)
- Kim ES, "Predictive factors of impaired quality of life in Korean patients with inactive inflammatory bowel disease : association with functional gastrointestinal disorders and mood disorders", J Clin Gastroenterol, 47, pp.e38~e44 (2013)
- Ueno F, "Impact of inflammatory bowel disease on Japanese patients' quality of life : results of a patient questionnaire survey", J Gastroenterol, 52, pp.555~567 (2017)
- Chang Kyun Lee, "A new opportunity for innovative inflammatory bowel disease research: the moderate-to-severe ulcerative colitis in Korea (MOSAIK) cohort study", Intestinal research, 17(1), pp.1~5 (2019), 대한장연구학회[DOI]
- Solberg IC, "Clinical course during the first 10 years of ulcerative colitis : results from a populationbased inception cohort(IBSEN Study)", Scand J Gastroenterol, 44, pp.431~440 (2009)
- Schroeder KW, "Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis : a randomized study", N Engl J Med, 317, pp.1625~1629 (1987)
- D'Haens G, "A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis", Gastroenterology, 132, pp.763~786 (2007)
- Zigmond AS, "The hospital anxiety and depression scale", Acta Psychiatr Scand, 67, pp.361~370 (1983)
- Oh SM, "A Study on the standardization of the hospital anxiety and depression scale for Koreans : a comparison of normal, depressed and anxious groups", J Korean Neuropsychiatr Assoc, 38, pp.289~296 (1999)
- Bernstein CN, "The validity and reliability of screening measures for depression and anxiety disorders in inflammatory bowel disease", Inflamm Bowel Dis, 24, pp.1867~1875 (2018)
- Reilly MC, "The validity and reproducibility of a work productivity and activity impairment instrument", Pharmacoeconomics, 4, pp.353~365 (1993)
- Pallis AG, "The inflammatory bowel disease questionnaire : a review of its national validation studies", Inflamm Bowel Dis, 10, pp.261~269 (2004)
- Guyatt G, "A new measure of health status for clinical trials in inflammatory bowel disease", Gastroenterology, 96, pp.804~810 (1989)
- Irvine EJ, "Quality of life : a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group", Gastroenterology, 106, pp.287~296 (1994)
- Ware J Jr, "A 12-Item Short-Form Health Survey : construction of scales and preliminary tests of reliability and validity", Med Care, 34, pp.220~233 (1996)
- Maruish ME, "A guide to the integration of certified Short Form survey scoring and data quality evaluation capabilities", Quality Metric Incorporated, ~ (2009)
- Kim SH, "Assessment of psychometric properties of the Korean SF-12 v2 in the general population", BMC Public Health, 14, pp.1086~ (2014)
- Mikocka-Walus A, "Controversies revisited : a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases", Inflamm Bowel Dis, 22, pp.752~762 (2016)
- Williet N, "Patient-reported outcomes in a French nationwide survey of inflammatory bowel disease patients", J Crohns Colitis, 11, pp.165~174 (2017)
- Goodhand JR, "Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease", Aliment Pharmacol Ther, 38, pp.1097~1108 (2013)
- Calloway A, "Depressive symptoms predict anti-tumor necrosis factor therapy noncompliance in patients with inflammatory bowel disease", Dig Dis Sci, 62, pp.3563~3567 (2017)
- Bennebroek Evertsz' F, "The effectiveness of cognitive behavioral therapy on the quality of life of patients with inflammatory bowel disease : multi-center design and study protocol(KL!C-study)", BMC Psychiatry, 12, pp.227~ (2012)
- Regueiro MD, "The inflammatory bowel disease specialty medical home : a new model of patient-centered care", Inflamm Bowel Dis, 22, pp.1971~1980 (2016)
- Lee CK, "Multidisciplinary team-based approaches to IBD management : how might"one-stop shopping"work for complex IBD care", Am J Gastroenterol, 112, pp.825~827 (2017)
- Siegel CA, "Development of an index to define overall disease severity in IBD", Gut, 67, pp.244~254 (2018)
- Huppertz-Hauss G, "Health-related quality of life in patients with inflammatory bowel disease 20 years after diagnosis : results from the IBSEN Study", Inflamm Bowel Dis, 22, pp.1679~1687 (2016)
- Lee CK, "A multidisciplinary approach to biopsychosocial care for adults with inflammatory bowel disease : a pilot study", Inflamm Bowel Dis, 24, pp.2550~2554 (2018)
- Szigethy EM, "White paper AGA : the impact of mental and psychosocial factors on the care of patients with inflammatory bowel disease", Clin Gastroenterol Hepatol, 15, pp.986~997 (2017)
- Keefer L, "Best practice update : incorporating psychogastroenterology into management of digestive disorders", Gastroenterology, 154, pp.1249~1257 (2018)
- Vavricka SR, "Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease", Inflamm Bowel Dis, 18, pp.496~505 (2012)